Skip to main content

Lacosamide

FDA recalls

4 rows

DateCompany and reasonClass
Jun 3, 2026Annora Pharma Private Limited
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.		Class II · Ongoing
Mar 12, 2025Glenmark Pharmaceuticals Inc., USA
CGMP Deviations		Class II · Ongoing
Dec 5, 2022Camber Pharmaceuticals, Inc
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content		Class III · Terminated
Mar 14, 2021Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.		Class II · Terminated

← Back to Lacosamide

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).